GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

GeneType is revolutionizing healthcare with its pioneering, non-invasive Multi-Risk Test, designed to uncover hidden risks of common yet serious diseases. This state-of-the-art test identifies individuals at elevated risk for a range of cancers, including breast, ovarian, pancreatic, prostate, colorectal, and melanoma, as well as cardiovascular diseases and metabolic conditions like Type 2 diabetes. Real Impact, Real Lives: About Genetic Technologies Limited Since the geneType Risk Assessment Tests became a ...